April 12, 2017
Gene silencing shows promise for treating two fatal neurological disorders
NIH-funded preclinical studies suggest designer drug may treat ALS and spinocerebellar ataxia 2.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: amyotrophic lateral sclerosis (ALS)